In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

ESC Congress 2017 Press Conference Details

--- This page is currently being updated --

Please be careful with embargo time: it lifts at the start of the scientific session! No longer at the press conference.



Saturday 26 August 15:00 to 16:00 - Cardiac Interventions - Expanding applications

Chairpersons:
Doctor Manel SABATE TENAS (Barcelona, Spain) - To be announced

Embargo CEST Presentation Title Presenter Resources
27 Aug. 2017 at 11:00 Percutaneous Coronary Intervention (PCI) has better prognosis than conservative treatment in patient over 80 years suffering from non ST-elevation myocardial Infarction (NSTEMI) Doctor Peter REINIUS (Stockholm, Sweden)

Slides

Press release

Webcast

26 Aug. 2017 at 11:00 Impact of BMI on clinical outcomes and readmissions after cardiac catheterization in the USA Doctor Afnan TARIQ (Orange, USA)

Slides

Press release

Webcast

28 Aug. 2017 at 14:00 Short- and long-term clinical outcomes in nonagenarian patients undergoing transcatheter aortic valve implantation Doctor Adriano CAIXETA (Sao Paolo, Brazil)

Slides

Press release

Webcast

26 Aug. 2017 at 11:00 Long-term comparative effectiveness of Transfemoral Transcatheter vs Surgical Aortic Valve Replacement: Results from the Italian OBSERVANT Study  To be announced

Slides

Press release

Webcast

 

Sunday 27 August 08:00-09:00 - Hot Line - Late Breaking Clinical Trials 1

Chairpersons:
Professor Barbara CASADEI (Oxford, United Kingdom) - Professor Steen Dalby KRISTENSEN (Aarhus, Denmark)

Embargo CEST Presentation Title Presenter Resources
27 Aug. 2017 at 11:00 Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure, the RACE 3 study Associate Professor Michiel RIENSTRA (Groningen, Netherlands)

Slides

Press release

Webcast

27 Aug. 2017 at 11:00 Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation: the CASTLE-AF trial Doctor Nassir MARROUCHE (Salt Lake City, USA)

Slides

Press release

Webcast

27 Aug. 2017 at 11:00 The Canakinumab Anti-Inflammatory Thrombosis Outcomes Study Doctor Paul M RIDKER (Boston, USA) 

Slides

Press release

Webcast

27 Aug. 2017 at 11:00 Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) trial: Primary Results Doctor John William EIKELBOOM (Hamilton, Canada)

Slides

Press release

Webcast

27 Aug. 2017 at 11:00 Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) trial: Results in Patients with Coronary Artery Disease and in patients with Peripheral Artery Disease Doctor Sonia ANAND (Hamilton, Canada)

Slides

Press release

Webcast

 

Sunday 27 August 09:00-10:00 - Living longer: Tips and Tricks

Chairpersons:
Professor Freek VERHEUGT (Amsterdam, Netherlands) - To be announced

Embargo CEST Presentation Title Presenter Resources
28 Aug. 2017 at 14:00 Marriage is associated with lower mortality rates in patients with acute coronary syndromes and modifiable cardiovascular risk factors Doctor Paul Richard CARTER (London, United Kingdom)

Slides

Press release

Webcast

27 Aug. 2017 at 11:00 Salt intake and the risk of heart failure Professor Pekka JOUSILAHTI (Helsinki, Finland)

Slides

Press release

Webcast

27 Aug. 2017 at 11:00 Coffee consumption and all-cause mortality in a Mediterranean cohort: the SUN project Doctor Adela NAVARRO (Pamplona, Spain)

Slides

Press release

Webcast

29 Aug. 2017 at 08:30 The impact of exercise volume on all-cause mortality, cardiovascular mortality and sudden cardiac arrest: a nationwide cohort study Doctor Young AH PARK (Seoul, Republic of Korea)

Slides

Press release

Webcast

 

Sunday 27 August 14:30-15:30 - Clinical Trials Update 1

Chairpersons:
Professor Ian Maklim GRAHAM (Wicklow, Ireland) - Professor Michael BOEHM (Homburg/Saar, Germany)

Embargo CEST Presentation Title Presenter Resources
28 Aug. 2017 at 14:00 Increased all-cause mortality with intensive blood-pressure control in patients with a baseline systolic blood pressure of >=160 mmHg and a Lower Framingham risk score: a cautionary note from SPRINT Professor Tzung-Dau WANG (Taipei City, Taiwan)

Slides

Press release

Webcast

28 Aug. 2017 at 14:00 Systolic Blood Pressure Variability and Major Adverse Outcomes in Patients with Atrial Fibrillation: the AFFIRM Study Doctor Marco PROIETTI (Birmingham, United Kingdom)

Slides

Press release

Webcast

8 Aug. 2017 at 14:00 Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor Evolocumab in the FOURIER Outcomes Trial Doctor Robert Patrick GIUGLIANO (Boston, USA)

Slides

Press release

Webcast

28 Aug. 2017 at 14:00 The long-term efficacy and safety of short dual antiplatelet therapy Professor Masato NAKAMURA (Tokyo, Japan)

Slides

Press release

Webcast

 Aug. 2017 at 14:00 Mechanisms for the benefit of spironolactone in resistant hypertension in the PATHWAY-2 study Professor Brian WILLIAMS (London, United Kingdom)

Slides

Press release

Webcast

28 Aug. 2017 at 14:00 Aldosterone Lethal Effects Blocked in Acute Myocardial Infarction Treated With or Without Repercussion to Improve Outcome and Survival at Six Months Follow-up Professor Farzin BEYGUI (Caen, France)

Slides

Press release

Webcast

 

Monday 28 August 08:00 to 09:00 - Hot Line - Late Breaking Clinical Trials 3

Chairpersons:
To be announced

Embargo CEST Presentation Title Presenter Resources
28 Aug. 2017 at 14:00 A Naturally Randomized Trial Comparing the Effect of Genetic Variants that Mimic CETP Inhibitors and Statins on the Risk of Cardiovascular Disease Professor Brian A FERENCE (Plymouth, USA) 

Slides

Press release

Webcast

28 Aug. 2017 at 14:00 Effect of Sildenafil on Clinical Outcomes in Patients with Corrected Valvular Heart Disease and Residual Pulmonary Hypertension Doctor Javier BERMEJO (Madrid, Spain)

Slides

Press release

Webcast

28 Aug. 2017 at 14:00 Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofem in Patients with Arthritis and Evidence of or with Increased Risk for Cardiovascular Disease Professor Frank RUSCHITZKA (Zurich, Switzerland) 

Slides

Press release

Webcast

28 Aug. 2017 at 14:00 Protection of the brain on occasion of planned open heart surgery by surgical closure of the left atrial appendage. A randomized study Doctor Jesper Park HANSEN (Frederiksberg, Denmark)

Slides

Press release

Webcast

28 Aug. 2017 at 14:00 AIRWAY MANAGEMENT DURING CARDIOPULMONARY RESUSCITATION: Tracheal intubation versus bag valve mask ventilation Professor Frederic ADNET (Bobigny, France)

Slides

Press release

Webcast

 

Monday 28 August 09:00 to 10:00 - Hot Line - Late Breaking Clinical Trials 2

Chairpersons:
Professor Stephan ACHENBACH (Erlangen, Germany) -  Doctor Sarah Catherine CLARKE (Cambridge, United Kingdom)

Embargo CEST Presentation Title Presenter Resources
28 Aug. 2017 at 11:00  SPYRAL HTN OFF-MED Study  To be announced

Slides

Press release

Webcast

28 Aug. 2017 at 11:00 Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial Professor Michael D EZEKOWITZ (Villanova, USA)

Slides

Press release

Webcast

28 Aug. 2017 at 11:00 An international multicenter clustered randomized trial to IMProve treatment with oral AntiCoagulanTs in Atrial Fibrilation Professor Christopher B GRANGER (Durham, USA)

Slides

Press release

Webcast

28 Aug. 2017 at 11:00 The Viborg Vascular randomised screening trial Professor Jes LINDHOLT (Odense, Denmark)

Slides

Press release

Webcast

28 Aug. 2017 at 11:00 Impact of a single or two dose regimen of inclisiran, a novel siRNA inhibitor to PCSK9 on time averaged reductions in LDL-C over 1 year. ORION 1 Professor Kausik K RAY (London, United Kingdom)

Slides

Press release

Webcast

28 Aug. 2017 at 11:00 DETermination of the role of OXygen in suspected Acute Myocardial Infarction Doctor Robin HAUFMANN (Stockholm, Sweden)

Slides

Press release

Webcast

 

Monday 28 August 13:00 to 14:00 - Hot Line - Late Breaking Clinical Trials 4

Chairpersons:
Professor Michel KOMAJDA (Paris, France) - Professor Hector BUENO (Madrid, Spain)

Embargo CEST Presentation Title Presenter Resources
29 Aug. 2017 at 08:30 Clinical effects of anacetrapib in people with established vascular disease: Results of the Randomized EValuation of the Effects of Anacetrapib through Lipid-modification (HPS3/TIMI55-REVEAL) trial Professor Martin LANDRAY (Oxford, United Kingdom)

Slides

Press release

Webcast

29 Aug. 2017 at 08:30 Does intensive treat-to-target LDL-C lowering therapy using statin in patients of diabetic retinopathy reduce cardiovascular events?: the EMPATHY study Professor Hiroshi ITOH (Tokyo, Japan)

Slides

Press release

Webcast

29 Aug. 2017 at 08:30 Exercise training in diastolic heart failure (Ex-DHF): a multicenter, prospective, randomized, controlled, parallel group trial Professor Frank EDELMANN (Berlin, Germany)

Slides

Press release

Webcast

29 Aug. 2017 at 08:30 Catheter Ablation compared with optimized Pharmacological Therapy for Atrial Fibrillation, a randomized multicentre study of quality of life and implantable cardiac monitoring after 12 month follow-up Professor Carina BLOMSTROM- LUNDQVIST (Uppsala, Sweden)

Slides

Press release

Webcast

29 Aug. 2017 at 08:30 Assessment of REmote HEArt Rhythm Sampling using the AliveCor heart monitor to scrEen for Atrial Fibrillation Professor Julian HALCOX (Swansea, United Kingdom)

Slides

Press release

Webcast

 

Tuesday 29 August 08:00 to 09:00 - Hot Line - Late Breaking Registry Results 1

Chairpersons:
Professor Steen Dalby KRISTENSEN (Aarhus, Denmark) - Doctor Laura MAURI (Boston, USA)

Embargo CEST Presentation Title Presenter Resources
29 Aug. 2017 at 11:00 Fruit, vegetable, and legume intake and cardiovascular disease and deaths: The Prospective Urban Rural Epidemiology (PURE) study of 135,000 people in 18 countries Assistant Professor Andrew MENTE (Hamilton, Canada)

Slides

Press release

Webcast

29 Aug. 2017 at 11:00 Dietary fats are protective but carbohydrates are harmful: First results of the PURE nutrition study on 135,000 people from 18 countries in 5 continents Doctor Mahshid DEHGHAN (Hamilton, Canada)

Slides

Press release

Webcast

29 Aug. 2017 at 11:00 Preexisting chronic kidney disease increases the risk of triggering acute myocardial infarction due to Asian dust exposure Associate Professor Sunao KOJIMA (Kumamoto, Japan)

Slides

Press release

Webcast

29 Aug. 2017 at 11:00 An international external validation study of the 2014 european society of cardiology guideline on sudden cardiac death prevention in hypertrophic cardiomyopathy Doctor Constantinos O'MAHONY (London, United Kingdom)

Slides

Press release

Webcast

29 Aug. 2017 at 11:00 Clopidogrel or Ticagrelor in Acute Coronary Syndrome Patients Treated With Newer-Generation Drug-Eluting Stents: CHANGE DAPT Professor Clemens VON BIRGELEN (Enschede, Netherlands)

Slides

Press release

Webcast

29 Aug. 2017 at 11:00 Pretreatment with P2Y12 Receptor Antagonists Is Not Associated with Improved Clinical Outcomes in STEMI: A report from SCAAR Professor Elmir OMEROVIC (Gothenburg, Sweden)

Slides

Press release

Webcast

Tuesday 29 August 09:00 to 10:00 - Cholesterol Lowering: Reality check and new directions

Chairpersons:
Professor Lina BADIMON (Barcelona, Spain) - Professor Kurt HUBER (Vienna, Austria)

Embargo CEST Presentation Title Presenter Resources
26Aug. 2017 at 12:35 Changes in lipid-lowering therapy prescription patterns following a second cardiovascular disease event Doctor Alanna CHAMBERLAIN (Rochester, USA)

Slides

Press release

Webcast

27 Aug. 2017 at 16:30 PCSK9 beyond its role in cholesterol homeostasis: co-activator of platelet function Doctor Laura ROSSETTI (Milano, Italy)

Slides

Press release

Webcast

26 Aug. 2017 at 11:00 Undertreatment of female patients in lipid-lowering for secondary prevention in Europe, Canada, South-Africa, Middle East and China: results of the dyslipidemia international study (dysis) Doctor Anselm Kai GITT (Ludwigshafen, Germany)

Slides

Press release

Webcast

28 Aug. 2017 at 10:05 Evolocumab lowers plasma Lp(a) concentration by two kinetic modes of action: From the FLOREY Study Doctor Gerald WATTS (Perth, Australia)

Slides

Press release

Webcast

 

New 2017 ESC Guidelines press releases

Guidelines released on Saturday 26 August 8:30 CEST

  • ESC Guidelines on AMI-STEMI
  • Focused Update on Dual Anti-Platelet Therapy
  • ESC Guidelines on the diagnosis and treatment of peripheral artery diseases
  • ESC Guidelines for the management of valvular heart diseases

Notes to editor

ESC Press Office
For press enquiries, please contact the ESC Press Office at media@escardio.org.

The press conference timetable is available here. 

To access all the scientific resources from the sessions during the congress, visit ESC Congress 365.  

About the European Society of Cardiology

The European Society of Cardiology brings together health care professionals from more than 120 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.

About ESC Congress 2016

ESC Congress is the world’s largest gathering of cardiovascular professionals contributing to global awareness of the latest clinical trials and breakthrough discoveries. ESC Congress 2016 takes place 27 to 31 August at the Fiera di Roma in Rome, Italy. The scientific programme is here. More information is available from the ESC Press Office at press@escardio.org